{"transactions":[{"id":2931929,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":144382,"kind":"person","name":"Tenzing LLC","position":1,"cik":"0001744957","reported_name":"Tenzing LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":2,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144383,"kind":"person","name":"Nayar Rahul","position":3,"cik":"0001744923","reported_name":"Nayar Rahul","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2020-12-28T20:02:07.000Z","date":"2020-12-15","kind":"other","acquired":false,"shares":540500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") agreed to transfer 540,500 warrants to acquire shares of common stock of the issuer to a certain shareholder of the issuer in exchange for such shareholder's agreement to waive and not to exercise any right to redeem or convert shares of the issuer in connection with the Business Combination. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants became exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") agreed to transfer 540,500 warrants to acquire shares of common stock of the issuer to a certain shareholder of the issuer in exchange for such shareholder's agreement to waive and not to exercise any right to redeem or convert shares of the issuer in connection with the Business Combination. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants became exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") agreed to transfer 540,500 warrants to acquire shares of common stock of the issuer to a certain shareholder of the issuer in exchange for such shareholder's agreement to waive and not to exercise any right to redeem or convert shares of the issuer in connection with the Business Combination. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants became exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") agreed to transfer 540,500 warrants to acquire shares of common stock of the issuer to a certain shareholder of the issuer in exchange for such shareholder's agreement to waive and not to exercise any right to redeem or convert shares of the issuer in connection with the Business Combination. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants became exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") agreed to transfer 540,500 warrants to acquire shares of common stock of the issuer to a certain shareholder of the issuer in exchange for such shareholder's agreement to waive and not to exercise any right to redeem or convert shares of the issuer in connection with the Business Combination. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants became exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") agreed to transfer 540,500 warrants to acquire shares of common stock of the issuer to a certain shareholder of the issuer in exchange for such shareholder's agreement to waive and not to exercise any right to redeem or convert shares of the issuer in connection with the Business Combination. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants became exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities held by the Sponsor are beneficially owned by Rahul Nayar and Parag Saxena, the issuer's Chairman, and the managing members of the Sponsor, who have joint voting and dispositive power over the securities held by the Sponsor. Mr. Nayar and Mr. Saxena disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2020-12-14","expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":540500},"source":{"system":"sec-edgar","filing":"0001104659-20-139934","document":"tm2039398d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465920139934/tm2039398d1_4.xml","form_type":"4"}},{"id":2931928,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":144382,"kind":"person","name":"Tenzing LLC","position":1,"cik":"0001744957","reported_name":"Tenzing LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":2,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144383,"kind":"person","name":"Nayar Rahul","position":3,"cik":"0001744923","reported_name":"Nayar Rahul","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2020-12-28T20:00:55.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":197500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), the issuer changed its corporate structure and domicile by way of continuation from an exempted company incorporated under the laws of the British Virgin Islands to a corporation incorporated under the laws of the State of Delaware (the \"Domestication\"). Pursuant to the Domestication, each outstanding ordinary share of the issuer was converted into one share of the issuer's common stock (the \"common stock\") and each outstanding public warrant of the issuer was converted into a warrant to acquire the common stock. The reporting person held 1,924,250 ordinary shares prior to the Business Combination, which were converted into 1,924,500 shares of common stock upon the Domestication."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Business Combination, Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") elected to convert an aggregate principal amount of $1,975,000 of promissory notes issued to the Sponsor by the issuer into 197,500 units, representing 197,500 shares of common stock and 197,500 warrants to purchase shares of common stock. These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person acquired beneficial ownership of the warrants in connection with the consummation of the Business Combination on December 14, 2020. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the consummation of the Business Combination, Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") elected to convert an aggregate principal amount of $1,975,000 of promissory notes issued to the Sponsor by the issuer into 197,500 units, representing 197,500 shares of common stock and 197,500 warrants to purchase shares of common stock. These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person acquired beneficial ownership of the warrants in connection with the consummation of the Business Combination on December 14, 2020. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the consummation of the Business Combination, Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") elected to convert an aggregate principal amount of $1,975,000 of promissory notes issued to the Sponsor by the issuer into 197,500 units, representing 197,500 shares of common stock and 197,500 warrants to purchase shares of common stock. These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person acquired beneficial ownership of the warrants in connection with the consummation of the Business Combination on December 14, 2020. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities held by the Sponsor are beneficially owned by Rahul Nayar and Parag Saxena, the issuer's Chairman, and the managing members of the Sponsor, who have joint voting and dispositive power over the securities held by the Sponsor. Mr. Nayar and Mr. Saxena disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest."}],"balance_after":540500,"derivative":{"exercise_price":11.5,"exercise_date":"2020-12-14","expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":197500},"source":{"system":"sec-edgar","filing":"0001104659-20-139933","document":"tm2039398d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465920139933/tm2039398d2_4.xml","form_type":"4"}},{"id":2931927,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":144382,"kind":"person","name":"Tenzing LLC","position":1,"cik":"0001744957","reported_name":"Tenzing LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":2,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144383,"kind":"person","name":"Nayar Rahul","position":3,"cik":"0001744923","reported_name":"Nayar Rahul","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2020-12-28T20:00:55.000Z","date":"2020-12-14","kind":"other","acquired":true,"shares":343000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), the issuer changed its corporate structure and domicile by way of continuation from an exempted company incorporated under the laws of the British Virgin Islands to a corporation incorporated under the laws of the State of Delaware (the \"Domestication\"). Pursuant to the Domestication, each outstanding ordinary share of the issuer was converted into one share of the issuer's common stock (the \"common stock\") and each outstanding public warrant of the issuer was converted into a warrant to acquire the common stock. The reporting person held 1,924,250 ordinary shares prior to the Business Combination, which were converted into 1,924,500 shares of common stock upon the Domestication."},{"field":"kind","element":"transactionCoding","label":"F5","text":"These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer. These warrants were acquired in connection with the issuer's initial public offering. Each whole warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Business Combination, Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") elected to convert an aggregate principal amount of $1,975,000 of promissory notes issued to the Sponsor by the issuer into 197,500 units, representing 197,500 shares of common stock and 197,500 warrants to purchase shares of common stock. These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person acquired beneficial ownership of the warrants in connection with the consummation of the Business Combination on December 14, 2020. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer. These warrants were acquired in connection with the issuer's initial public offering. Each whole warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer. These warrants were acquired in connection with the issuer's initial public offering. Each whole warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities held by the Sponsor are beneficially owned by Rahul Nayar and Parag Saxena, the issuer's Chairman, and the managing members of the Sponsor, who have joint voting and dispositive power over the securities held by the Sponsor. Mr. Nayar and Mr. Saxena disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest."}],"balance_after":343000,"derivative":{"exercise_price":11.5,"exercise_date":"2020-12-14","expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":343000},"source":{"system":"sec-edgar","filing":"0001104659-20-139933","document":"tm2039398d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465920139933/tm2039398d2_4.xml","form_type":"4"}},{"id":2931926,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":144382,"kind":"person","name":"Tenzing LLC","position":1,"cik":"0001744957","reported_name":"Tenzing LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":2,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144383,"kind":"person","name":"Nayar Rahul","position":3,"cik":"0001744923","reported_name":"Nayar Rahul","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T20:00:55.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":197500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the consummation of the Business Combination, Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") elected to convert an aggregate principal amount of $1,975,000 of promissory notes issued to the Sponsor by the issuer into 197,500 units, representing 197,500 shares of common stock and 197,500 warrants to purchase shares of common stock. These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person acquired beneficial ownership of the warrants in connection with the consummation of the Business Combination on December 14, 2020. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Business Combination, Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") elected to convert an aggregate principal amount of $1,975,000 of promissory notes issued to the Sponsor by the issuer into 197,500 units, representing 197,500 shares of common stock and 197,500 warrants to purchase shares of common stock. These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person acquired beneficial ownership of the warrants in connection with the consummation of the Business Combination on December 14, 2020. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Immediately prior to the consummation of the issuer's initial business combination on December 14, 2020 (the \"Business Combination\"), the issuer changed its corporate structure and domicile by way of continuation from an exempted company incorporated under the laws of the British Virgin Islands to a corporation incorporated under the laws of the State of Delaware (the \"Domestication\"). Pursuant to the Domestication, each outstanding ordinary share of the issuer was converted into one share of the issuer's common stock (the \"common stock\") and each outstanding public warrant of the issuer was converted into a warrant to acquire the common stock. The reporting person held 1,924,250 ordinary shares prior to the Business Combination, which were converted into 1,924,500 shares of common stock upon the Domestication."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In connection with the consummation of the Business Combination, Tenzing LLC (the \"Reporting Person\" or the \"Sponsor\") elected to convert an aggregate principal amount of $1,975,000 of promissory notes issued to the Sponsor by the issuer into 197,500 units, representing 197,500 shares of common stock and 197,500 warrants to purchase shares of common stock. These warrants underlie units consisting of one share of common stock and one warrant, which were purchased by the Reporting Person for $10.00 per unit on August 20, 2018, pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person acquired beneficial ownership of the warrants in connection with the consummation of the Business Combination on December 14, 2020. Each warrant is exercisable to purchase one share of common stock, subject to adjustment pursuant to the terms of the warrants. The warrants become exercisable on December 14, 2020 and expire at 5:00 p.m., New York City time, on December 14, 2025, or earlier upon their redemption or the liquidation of the issuer pursuant to the terms of the warrants."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities held by the Sponsor are beneficially owned by Rahul Nayar and Parag Saxena, the issuer's Chairman, and the managing members of the Sponsor, who have joint voting and dispositive power over the securities held by the Sponsor. Mr. Nayar and Mr. Saxena disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest."}],"balance_after":2121750,"source":{"system":"sec-edgar","filing":"0001104659-20-139933","document":"tm2039398d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465920139933/tm2039398d2_4.xml","form_type":"4"}},{"id":3826902,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":144382,"kind":"person","name":"Tenzing LLC","position":1,"cik":"0001744957","reported_name":"Tenzing LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-09-04T21:02:03.000Z","date":"2018-08-30","kind":"purchase","acquired":true,"shares":33000,"price":10,"value":330000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are underlying units (each unit consisting of one ordinary share and one warrant, each warrant exercisable to purchase one share) held by Tenzing LLC (the \"Sponsor\"), acquired pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer in connection with the exercise of the underwriters' over-allotment option pursuant to the issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares held by the Sponsor are beneficially owned by Rahul Nayar and Parag Saxena, the issuer's Chief Executive Officer and Chairman, respectively, and the managing members of the Sponsor, who have joint voting and dispositive power over the shares held by the Sponsor. Mr. Nayar and Mr. Saxena disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest."}],"balance_after":1924250,"source":{"system":"sec-edgar","filing":"0001144204-18-047846","document":"tv502261_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000114420418047846/tv502261_4.xml","form_type":"4"}},{"id":3833504,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":144382,"kind":"person","name":"Tenzing LLC","position":1,"cik":"0001744957","reported_name":"Tenzing LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-24T21:00:50.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":310000,"price":10,"value":3100000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are underlying units (each unit consisting of one ordinary share and one warrant, each warrant exercisable to purchase one share) held by Tenzing LLC (the \"Sponsor\"), acquired pursuant to an amended and restated unit subscription agreement by and between the Sponsor and the issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares held by the Sponsor are beneficially owned by Rahul Nayar and Parag Saxena, the issuer's Chief Executive Officer and Chairman, respectively, and the managing members of the Sponsor, who have joint voting and dispositive power over the shares held by the Sponsor. These shares include up to an aggregate of 206,250 ordinary shares subject to forfeiture by the Sponsor to the extent that the underwriters' over-allotment option is not exercised in full. Mr. Nayar and Mr. Saxena disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest."}],"balance_after":1891250,"source":{"system":"sec-edgar","filing":"0001144204-18-046296","document":"tv501623_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000114420418046296/tv501623_4.xml","form_type":"4"}}]}